NCT04538534View on ClinicalTrials.gov

Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention

PHASE3CompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Spasm Artery
Interventions
DRUG

Nicardipine

To compare the association of nicardipine and isosorbide dinitrate vs isosorbide dinitrate alone on the rate of occurrence of radial artery spasm

Trial Locations (1)

5000

CHU Fattouma Bourguiba, Monastir

All Listed Sponsors
lead

Pr. Semir Nouira

OTHER

NCT04538534 - Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter